Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection
Albert Einstein College of Medicine · Montefiore Medical Center · +2 more institutions
Abstract
To date, evidence for the efficacy of fecal microbiota transplantation (FMT) in recurrent Clostridium difficile infection (CDI) has been limited to case series and open-label clinical trials.
To determine the efficacy and safety of FMT for treatment of recurrent CDI.
Citation impact
- FWCI
- 54.19
- Percentile
- 100%
- References
- 29
Authors
13- CKColleen KellyCorresponding
Albert Einstein College of Medicine, Montefiore Medical Center
- AKAlexander Khoruts
University of Minnesota, University of Rhode Island, Albert Einstein College of Medicine, Montefiore Medical Center
- CSChristopher Staley
Montefiore Medical Center, Albert Einstein College of Medicine, University of Minnesota, University of Rhode Island
- MJMichael J. Sadowsky
Montefiore Medical Center, Albert Einstein College of Medicine, University of Rhode Island, University of Minnesota
- MAMortadha Abd
Albert Einstein College of Medicine, University of Rhode Island, University of Minnesota, Montefiore Medical Center
Topics & keywords
- Medicine
- Clostridium difficile
- Colonoscopy
- Adverse effect
- Internal medicine
- Fecal bacteriotherapy
- Diarrhea
- Transplantation
- Good health and well-being